Patients with heavily calcified coronary lesions treated with a 2-Hz intravascular lithotripsy catheter have low MACE rates at 1 year.

The FDA is expected to make decisions on novel agents for stroke prevention, myasthenia gravis, primary biliary cholangitis, GIST, and breast cancer.

A new generic hormone therapy patch used to treat symptoms of menopause will be available following recent FDA approval.

There is an association between osteoporosis / osteopenia and enzyme-inducing antiseizure drugs, but vitamin D supplementation remains underutilized.

GLP-1 RA exposure is associated with earlier sequential NAION among patients with non-arteritic anterior ischemic optic neuropathy.

A noninvasive hemodynamic staging system separates patients with ATTR-CM into distinct prognostic categories, according to a recent study.

Spatial frequency domain imaging offers noninvasive measures of skin involvement, aligning with established assessments for systemic sclerosis.

Elevated maternal body mass index and excessive weight gain during pregnancy increase the risk of early-onset CVD in offspring.

Thomas Nero, MD, host of the Future Pulse Cardiology podcast, has partnered with Cardiology Advisor and Haymarket Media to distribute podcast episodes as part of Haymarket’s Adv ...

Higher ultraprocessed food intake is associated with greater odds of vascular brain injury and adiposity, but not cognitive performance.

Adding evolocumab to lipid-lowering therapy reduces all-cause mortality in high-risk patients without a history of myocardial infarction or stroke.

Gossamer Bio has submitted a New Drug Application to the FDA seeking approval of seralutinib for pulmonary arterial hypertension (PAH).